Assets Alterar Data
AbbVie USD 136.22B 854M 2023-09
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Akebia Therapeutics USD 241.7M 6.7M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Baxter International USD 28.28B 2.38B 2023-12
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Fujifilm JPY 4.53T 152.38B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Ironwood Pharmaceuticals USD 471.07M 52.99M 2023-12
Merck USD 106.73B 2.26B 2023-09
Myriad Genetics USD 1.15B 2.6M 2023-12
Pacira USD 1.57B 39.92M 2023-12
Perrigo USD 10.76B 206.4M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Revance Therapeutics USD 532.49M 65.05M 2023-09
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09
Xencor USD 952.69M 174.26M 2023-12
Zoetis USD 14.29B 180M 2023-12



Coherus Biosciences Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.